PROTOCOL ACTIVATION

NRG-GI005: Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA

Colon Cancer (COBRA) 

Activation: December 16, 2019

NCI Version Date: September 16, 2019

Documents for this study are posted on CTSU.

 

 

Twitter

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe